Removal of age restriction for glucocorticoid injections of keloid lesions (MBS Item 30210)

This page provides information on the 1 November 2021 change to MBS item 30210

Page last updated: 11 October 2021

From 1 November 2021, an age restriction governing eligibility for glucocorticoid injections of keloid lesions will be removed. Patients will have access to a clinically relevant service irrespective of age.

PDF version factsheet – Keloid lesion injection – 1 November 2021 (PDF 202 KB)
Word version factsheet – Keloid lesion injection – 1 November 2021 (Word 82 KB)


In this section